|
|
Transcript: FDA FOREIGN DRUG INSPECTION PROGRAM:DAVID NELSON
- Article from:
- Congressional Testimony
- Article date:
- April 29, 2008
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Congressional Testimony
04-29-2008
Statement of David Nelson Senior Investigator Committee on Energy and Commerce
Committee on House Energy and Commerce Subcommittee on Oversight and Investigations
April 29, 2008 This is the fourth in a series of Subcommittee hearings
concerning the Food and Drug Administration`s (FDA) ability to adequately
protect Americans from unsafe foreign manufactured pharmaceuticals. Today,
the staff is prepared to summarize the results of its investigation of
the events that led to at least 81 deaths and hundreds of severe allergic
reactions associated with the manufacture of contaminated heparin, a blood
thinner used widely in surgery and dialysis whose active ingredient ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA flub tied to heparin scare
Tribune-Review/Pittsburgh Tribune-Review;
February 19, 2008 ;
700+ words
... ... for inspection." Changzhou SPL was confused with ... Therefore, the FDA did not inspect Changzhou SPL before approving Baxter ... the company. The FDA would not reveal the ... company it confused with Changzhou SPL, but a spokeswoman ...
|
|